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Objectives. This study sought to investigate the clinical charac-
teristics of patients with chronic heart failure and an increased
ventilatory response to exercise and to examine the prognostic
usefulness of this response.
Background. The ventilatory response to exercise is increased
in many patients with chronic heart failure and may be charac-
terized by the regression slope relating minute ventilation to
carbon dioxide output (V˙E–V˙CO2 slope) during exercise.
Methods. One hundred seventy-three consecutive patients (155
men; mean [6SD] age 59.8 6 11.5 years; radionuclide left
ventricular ejection fraction [LVEF] 28.4 6 14.6%) underwent
cardiopulmonary exercise testing (peak oxygen consumption
18.5 6 7.3 ml/kg per min; V˙E–V˙CO2 slope 34.8 6 10.6) over a 2-year
period. Using 1.96 standard deviations above the mean V˙E–V˙CO2
slope of 68 healthy age-matched subjects (mean slope 26.3 6 4.1),
we defined a high ventilatory response to exercise as a slope >34.
Results. Eighty-three patients (48%) had an increased V˙E–V˙CO2
slope (mean 43.1 6 8.9). There was a difference in age (62.2 vs.
57.3 years, p 5 0.005), New York Heart Association functional
class (2.9 vs. 2.1, p < 0.001), LVEF (24.7 vs. 31.9%, p 5 0.0016),
peak oxygen consumption (14.9 vs. 21.7 ml/kg per min, p <
0.0001) and radiographic cardiothoracic ratio (0.58 vs. 0.55, p 5
0.002) between these patients and those with a normal slope. In
the univariate Cox proportional hazards model, the V˙E–V˙CO2 slope
was an important prognostic factor (p < 0.0001). In the multi-
variate Cox analyses using several variables (age, peak oxygen
consumption, V˙E–V˙CO2 slope and LVEF), the V˙E–V˙CO2 slope gave
additional prognostic information (p 5 0.018) beyond peak oxy-
gen consumption (p 5 0.022). Kaplan-Meier survival curves at 18
months demonstrated a survival rate of 95% in patients with a
normal V˙E–V˙CO2 slope compared with 69% in those with a high
slope (p < 0.0001).
Conclusions. A high V˙E–V˙CO2 slope selects patients with more
severe heart failure and is an independent prognostic marker. The
V˙E–V˙CO2 slope may be used as a supplementary index in the
assessment of patients with chronic heart failure.
(J Am Coll Cardiol 1997;29:1585–90)
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Chronic heart failure is a common condition with high mor-
bidity and mortality. It has a prevalence of 4.5% in the
population between 65 and 74 years old and an overall 5-year
survival rate of ,40% (1). Symptoms of chronic heart failure,
such as dyspnea and fatigue, are debilitating and manifest
especially during exertion. Although indexes such as left
ventricular ejection fraction (LVEF), ventricular dimensions
and hemodynamic measurements reflect the degree of cardiac
dysfunction, there is little correlation between these variables
and exercise capacity (2–5). Exercise testing therefore remains
an important and objective means of assessing the functional
capacity of these patients, especially when coupled to respira-
tory gas exchange analysis (6–10). During such cardiopulmo-
nary exercise testing, peak oxygen consumption during exercise
is traditionally used as the major index of functional impair-
ment (11–14). Peak oxygen consumption has also been used in
the assessment of response to therapy and in the triage of
patients with chronic heart failure awaiting heart transplanta-
tion (15). However, it has important limitations and may not be
accurately obtained because a plateau is not always reached at
peak exercise (16). It is also influenced by the motivation of
patients (17).
During cardiopulmonary exercise testing, a close linear
relation exists between carbon dioxide output (V˙CO2) and
minute ventilation (V˙E); this relation is more linear and less
variable than that between oxygen consumption and minute
ventilation (18,19). The slope of the regression line relating
carbon dioxide output and minute ventilation (V˙E–V˙CO2 slope)
can therefore be used to describe the ventilatory response to
exercise (20–22). Much interest has been directed toward the
excessive exercise ventilatory response demonstrated in pa-
tients with chronic heart failure, characterized by a steeper
V˙E–V˙CO2 slope (5,21–26). This steeper slope is associated with
reduced cardiac output during exercise (5,23), increased pul-
monary artery and capillary wedge pressures (5,23), increased
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dead space/tidal volume ratio (5,23,26) and, more recently, an
augmented chemoreceptor sensitivity (27). In summary, it is
still not precisely known whether the increased ventilatory
response to exercise in patients with chronic heart failure is
predominantly due to reduced pulmonary perfusion and he-
modynamic abnormalities causing ventilation–perfusion mis-
matching or to the altered control of ventilation, as suggested
by the augmentation in chemosensitivity. The latter, in turn,
may be related to sympathetic overactivity (27), abnormal
potassium metabolism (28,29), ergoreflex activation (30), early
lactic acidosis (31) or altered central command (32). The
mechanisms causing an increased ventilatory response to ex-
ercise may well be multifactorial.
Other than being steeper, the V˙E–V˙CO2 slope has also been
observed to be inversely correlated with peak oxygen consump-
tion in patients with chronic heart failure (22,23). Therefore,
we reasoned that it may be used as a supplementary index in
the assessment of patients with chronic heart failure. However,
there are to date no comprehensive data on the clinical
characteristics of patients with chronic heart failure exhibiting
an excessive ventilatory response to exercise. The prognostic
significance of an increased V˙E–V˙CO2 slope in patients with
chronic heart failure is also not known.
The aims of our study were to 1) determine the normal
values of the ventilatory response to exercise in healthy
subjects; 2) characterize patients with chronic heart failure
exhibiting an abnormally high ventilatory response to exercise
in terms of clinical indexes of severity, including peak oxygen
consumption, LVEF, radiographic cardiothoracic ratio and
New York Heart Association functional class; and 3) investi-
gate the usefulness of the ventilatory response to exercise as a
prognostic index of survival in patients with chronic heart
failure.
Methods
Patients. One hundred seventy-three consecutive patients
with chronic heart failure who performed a cardiopulmonary
exercise test over a 2-year period between January 1993 and
December 1994 inclusive were studied retrospectively. Tread-
mill cardiopulmonary exercise testing was performed using a
modified Bruce protocol (33) with the addition of a “stage 0”
at 1.0 mph and a 5% gradient. All patients were encouraged to
exercise to exhaustion, with a peak respiratory exchange ratio
.1.1. Respiratory gas exchange analysis was carried out by
respiratory mass spectrometry (Amis 2000, Innovision,
Odense, Denmark) every 10 s using the inert gas dilution
technique (34). The V˙E–V˙CO2 slope was calculated by linear
regression analysis using the above values of minute ventilation
and carbon dioxide output obtained every 10 s of the exercise.
In all patients, the regression coefficient was .0.93 (mean
[6SD] 0.98 6 0.01). Both minute ventilation and carbon
dioxide output were measured in liters/min, and thus the slope
has no dimensions.
To define an excessive ventilatory response to exercise, the
cardiopulmonary exercise data of 68 age-matched healthy
subjects were analyzed. Using 1.96 standard deviations above
the mean level of the V˙E–V˙CO2 slope in the healthy subjects,
we defined an abnormally high ventilatory response to exercise
as .34. Before cardiopulmonary exercise testing, spirometric
lung function tests were also performed. The characteristics of
the healthy subjects and patients are shown in Table 1.
Most patients were followed up at the outpatient clinic of
our hospital. Other variables analyzed in this study included
Abbreviations and Acronyms
CI 5 confidence interval
HR 5 hazard ratio
FEV1 5 forced expiratory volume in 1 s
FVC 5 forced vital capacity
LVEF 5 left ventricular ejection fraction
V˙CO2 5 carbon dioxide output
V˙E 5 minute ventilation
V˙E–V˙CO2 slope 5 slope of regression relating minute ventilation to
carbon dioxide output
Table 1. Characteristics of Healthy Subjects and Patients With
Chronic Heart Failure
Healthy
Subjects
(n 5 68)
Patients
With CHF
(n 5 173)
Age (yr) 56.4 6 9.5 59.8 6 11.5
Men/women 56/12 155/18
Height (cm) 174.4 6 9.5 173.1 6 8.5
Weight (kg) 78.2 6 13.1 78.4 6 13.8
FEV1 (% predicted) 113.9 6 26.2 85.8 6 22.6
FVC (% predicted) 119.0 6 24.1 89.5 6 20.5
Peak O2 consumption (ml/kg per min) 32.5 6 8.3 18.5 6 7.3
V˙E–V˙CO2 slope
Overall 26.3 6 4.1 34.8 6 10.6
Men 26.2 6 4.1 34.4 6 10.6
Women 26.6 6 4.1 35.6 6 7.6
Etiology of CHF
IHD 96
DCM 69
Others* 8
NYHA functional class
I 30
II 57
III 61
IV 25
LVEF (%) 28.4 6 14.6
Radiographic CTR 0.56 6 0.06
Furosemide n 5 173
ACE inhibitor n 5 124
*Valvular heart disease in six patients, hypertension related in two. Data
presented are mean value 6 SD or number of patients. ACE 5 angiotensin-
converting enzyme; CHF 5 chronic heart failure; CTR 5 cardiothoracic ratio;
DCM 5 dilated cardiomyopathy; FEV1 5 forced expiratory volume in 1 s;
FVC 5 forced vital capacity; IHD 5 ischemic heart disease; LVEF 5 left
ventricular ejection fraction; NYHA 5 New York Heart Association; V˙E–V˙CO2
slope 5 regression slope relating minute ventilation and carbon dioxide output
during exercise.
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age, etiology of chronic heart failure, New York Heart Asso-
ciation functional class, peak oxygen consumption, radionu-
clide multigated acquisition (MUGA) LVEF, radiographic
cardiothoracic ratio and medication. Mortality data were ob-
tained through outpatient clinic attendance records and tele-
phone interviews with the patients or with the patients’ primary
care physician, where appropriate. Seven patients were lost to
follow-up. Our study focused on all-cause mortality.
Studies of reproducibility. The reproducibility of the ven-
tilatory response to exercise as characterized by the V˙E–V˙CO2
slope was previously assessed in our laboratory. There was
good agreement between repeated measures (r 5 0.93, p ,
0.001) in 20 patients with chronic heart failure, with a mean
coefficient of variation of 6.2%.
Statistical analysis. The significance of results was as-
sessed using a two-tailed Student t test and the relation
between variables using linear regression analysis, where ap-
propriate. Chi-square testing was used for analysis of categoric
data. The prognostic value of the V˙E–V˙CO2 slope and other
clinical variables (age, chronic heart failure etiology, LVEF,
exercise time, peak oxygen consumption, functional class and
radiographic cardiothoracic ratio) were assessed using a Cox
proportional hazards regression model. Kaplan-Meier esti-
mates of the survival function were accordingly plotted for
patients with normal and high V˙E–V˙CO2 slopes; p , 0.05 was
considered significant.
Results
Patients (Table 1). The mean age of patients was 59.8 6
11.5 years; peak oxygen consumption was 18.5 6 7.3 ml/kg per
min; radionuclide LVEF was 28.4 6 14.6%; and the mean
V˙E–V˙CO2 slope was 34.8 6 10.6. There was an inverse relation
between peak oxygen consumption and V˙E–V˙CO2 slope (r 5
20.53, p , 0.0001), in agreement with previous studies, as
shown in Figure 1. The mean age of the healthy subjects in our
study was 56.4 6 9.5 years; peak oxygen consumption was
32.5 6 8.3 ml/kg per min; and the mean V˙E–V˙CO2 slope was
26.3 6 4.1. There was no significant difference in mean
V˙E–V˙CO2 slope between healthy men and women in our study,
as shown in Table 1.
Using the V˙E–V˙CO2 slope of healthy subjects, we defined an
abnormally high ventilatory response to exercise as .34
(.mean 6 1.96 SD). The V˙E–V˙CO2 slope was below this value
(mean 27.2 6 4.4) in 90 patients (52%) and above this value
(mean 43.1 6 8.9) in 83 (48%). The clinical characteristics of
these two groups of patients were analyzed on the basis of
these findings, as follows.
Age, chronic heart failure etiology and functional class.
Patients with an increased ventilatory response to exercise
were older than those with a normal response (62.2 6 9.4 vs.
57.3 6 12.6 years, p 5 0.005) and were also in a higher
functional class (2.9 vs. 2.1, p , 0.001). However, the ventila-
tory response to exercise was not different in patients with
idiopathic dilated cardiomyopathy (n 5 69, V˙E–V˙CO2 slope
34.3 6 10.4) and those with ischemic heart disease (n 5 96,
V˙E–V˙CO2 slope 35.7 6 10.8).
Lung function test. The lung function tests were more
impaired in patients with an increased ventilatory response to
exercise than in those with a normal response. The forced
expiratory volume in 1 s (FEV1) and forced vital capacity
(FVC), expressed in terms of percentage predicted, were 79 6
23% versus 93 6 20% for FEV1 and 85 6 21% versus 94 6
19% for FVC (p 5 0.002 and 0.004, respectively).
Cardiopulmonary exercise variables. Patients with a high
ventilatory response to exercise had a reduced peak oxygen
consumption (14.9 6 5.7 vs. 21.7 6 7.1 ml/kg per min, p ,
0.0001), and exercise duration was shorter (410 6 173 vs.
583 6 202 s, p , 0.0001). Rest heart rate was not different in
the two groups (87 6 18 vs. 84 6 18 beats/min, p 5 0.4), but
heart rate at peak exercise was lower in patients with a high
V˙E–V˙CO2 slope (136 6 26 vs. 146 6 25 beats/min, p 5 0.01).
Both rest and peak exercise systolic blood pressure were lower
in patients with a high ventilatory response to exercise (118 6
26 vs. 128 6 23 mm Hg, p 5 0.009 and 142 6 33 vs. 163 6
35 mm Hg, p , 0.0001, respectively).
Radionuclide LVEF and radiographic cardiothoracic ratio.
LVEF was lower (24.7 6 13.1% vs. 31.9 6 14.7%, p 5 0.0016)
and the radiographic cardiothoracic ratio greater in patients
with an increased ventilatory response to exercise (0.58 6 0.07
vs. 0.55 6 0.05, p 5 0.002).
Medication. Patients with an increased ventilatory re-
sponse to exercise received an increased dose of furosemide
daily, although this dose did not reach statistical significance
(84.8 vs. 75.9 mg, p 5 0.43). An equal number of patients (n 5
62) in each group received angiotensin-converting enzyme
inhibitors.
Survival analysis. The mean duration of follow-up (n 5
166) was 759 6 340 days (range 4 to 1,484). Thirty-six patients
died during follow-up, and heart transplantation was per-
formed in two. Although the latter were alive at the time of
study data analysis, each heart transplantation was classified as
equivalent to a death for analysis purposes. For survivors, the
duration of follow-up was 889 6 229 days (range 595 to 1,484).
Of those who died, the duration of follow-up was 322 6 285
Figure 1. Inverse relation between peak oxygen consumption and
ventilatory response to exercise (V˙E–V˙CO2 slope) in patients with
chronic heart failure.
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days (range 4 to 1,166). The overall 1-year cumulative survival
rate was 86% (23 deaths).
There was no difference in age and etiology of heart failure
between survivors and nonsurvivors (Table 2). However, those
who died were in a higher functional class (p , 0.0001) and
had reduced peak oxygen consumption (p , 0.0001) and
exercise duration (p , 0.0001) and a lower LVEF (p , 0.002).
The V˙E–V˙CO2 slope was also significantly higher (41.9 6 14.1
vs. 32.3 6 7.8, p , 0.0001). In contrast, the radiographic
cardiothoracic ratio was not significantly different (p 5 0.19).
In the univariate Cox proportional hazards model, exercise
duration, peak oxygen consumption, functional class, LVEF
and V˙E–V˙CO2 slope were significant prognostic indicators
(Table 3). With multivariate analyses using two variables, the
V˙E–V˙CO2 slope remained an important prognostic indicator
independent of age, peak oxygen consumption, functional
class, exercise duration and LVEF. With multivariate analyses
using peak oxygen consumption, exercise duration and V˙E–
V˙CO2 slope as covariates, only the V˙E–V˙CO2 slope (hazard ratio
[HR] 1.046, 95% confidence interval [CI] 1.013 to 1.080, p 5
0.006) and peak oxygen consumption (HR 0.874, 95% CI 0.780
to 0.979, p 5 0.02), but not exercise duration (HR 1.001, 95%
CI 0.998 to 1.004, p 5 0.59), provided prognostic information.
With multivariate analyses using age, peak oxygen consump-
tion, LVEF and the V˙E–V˙CO2 slope as covariates, the V˙E–V˙CO2
slope again provided additional prognostic information beyond
peak oxygen consumption (Table 4). When Kaplan-Meier
survival curves censored at 1 year were constructed, patients
with a normal V˙E–V˙CO2 regression slope had a survival rate of
98% (2 deaths) compared with 73% (21 deaths) in those with
a high V˙E–V˙CO2 slope (p , 0.0001). Kaplan-Meier survival
curves for 18 months of follow-up (547 days) showed a survival
rate of 95% (4 deaths) for patients with a normal V˙E–V˙CO2
slope and 69% (24 deaths) for patients with a high V˙E–V˙CO2
slope (p , 0.0001), as shown in Figure 2.
Discussion
General findings. Our study confirms previous observa-
tions that the exercise ventilatory response is increased in some
patients with chronic heart failure, as demonstrated by a higher
V˙E–V˙CO2 slope. It also confirms the inverse relation between
peak oxygen consumption and the V˙E–V˙CO2 slope. However,
the modest correlation suggests that although these two vari-
ables are related, they are determined by different factors. As
shown by our study, the slope is abnormal in ;50% of patients
with heart failure. These patients were in a higher functional
class. Patients with an increased ventilatory response to exer-
cise also demonstrated poorer exercise tolerance, as indicated
by a reduced peak oxygen consumption. Heart rate and blood
pressure response at peak exercise were also reduced; LVEF
Table 2. Clinical Characteristics of Patients With Chronic Heart
Failure: Survivors Versus Nonsurvivors*
Survivors
(n 5 128)
Nonsurvivors
(n 5 38)
p
Value
Age (yr) 59.3 6 11.8 62.0 6 11.0 0.2
Men/women 113/15 35/3 0.5
Etiology (DCM/IHD) 51/69 14/24 . 0.5
NYHA functional class 2.2 3.2 , 0.0001
LVEF (%) 31.1 6 14.6 22.8 6 14.7 0.002
Radiographic CTR 0.55 6 0.06 0.57 6 0.06 0.19
Peak O2 consumption
(ml/kg per min)
20.0 6 6.9 14.0 6 6.8 , 0.0001
V˙E–V˙CO2 slope 32.3 6 7.8 41.9 6 14.1 , 0.0001
Exercise time (s) 540.1 6 197.5 394.3 6 194.4 , 0.0001
*Seven patients were lost to follow-up for survival analysis (thus, n 5 166).
Data presented are mean value 6 SD or number of patients. Abbreviations as in
Table 1.
Table 3. Univariate Cox Regression Analysis of Association Between Variables Studied and
Survival Time
Variable
r
Coeff SE
p
Value HR (95% CI)
Age 0.021 0.015 0.15 1.023 (0.993–1.053)
Gender 2 0.049 0.53 0.9 0.952 (0.337–2.688)
Etiology 2 0.069 0.279 0.8 0.933 (0.540–1.613)
NYHA functional class 1.055 0.201 , 0.0001 2.872 (1.936–4.262)
LVEF 2 0.041 0.14 0.003 0.959 (0.934–0.986)
Radiographic CTR 3.612 2.66 0.17 37.04 (0.202–6,807.5)
Peak O2 consumption 2 0.169 0.036 , 0.0001 0.845 (0.787–0.907)
Ventilatory response to exercise
(V˙E–V˙CO2 slope)
0.077 0.13 , 0.0001 1.080 (1.053–1.107)
Exercise time 2 0.003 0.001 0.0002 0.997 (0.995–0.998)
CI 5 confidence interval; Coeff 5 coefficient; HR 5 hazard ratio; other abbreviations as in Table 1.
Table 4. Multivariate Cox Regression Analysis of Study Variables*
Variable
r
Coeff SE
p
Value HR (95% CI)
Age 0.001 0.018 0.95 1.001 (0.967–1.037)
Peak O2 consumption 2 0.095 0.042 0.022 0.909 (0.838–0.987)
V˙E–V˙CO2 slope 0.039 0.017 0.018 1.040 (1.007–1.074)
LVEF 2 0.022 0.014 0.122 0.978 (0.952–1.006)
*V˙E–V˙CO2 provided additional prognostic information beyond peak oxygen
consumption. Abbreviations as in Tables 1 and 3.
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was lower and radiographic cardiothoracic ratio larger. In
short, the ventilatory response to exercise reflects the severity
of heart failure patients from several aspects, namely, clinical
symptoms (functional class), cardiac function (LVEF, radio-
graphic cardiothoracic ratio, heart rate and blood pressure
response) and functional capacity (peak oxygen consumption).
The findings were unlikely to be affected by medication, such
as angiotensin-converting enzyme inhibitors, because the num-
ber of patients receiving this medication was similar in both
patient groups. The V˙E–V˙CO2 slope may therefore be a useful
supplementary measurement in the assessment of patients with
chronic heart failure and one that could easily be obtained
during cardiopulmonary exercise testing.
In our study, patients who had an increased ventilatory
response to exercise were slightly older. Age has been previ-
ously shown to affect the ventilatory response to exercise both
in healthy subjects (35) and in patients with chronic heart
failure (5). The reasons for this are not known but may reflect
declining ventilatory efficiency with age. Pulmonary function
tests in terms of FEV1 and FVC were also more impaired in
patients with an increased V˙E–V˙CO2 slope. It may be that
severe heart failure is associated with worse parenchymal lung
disease, as observed by other workers (36,37).
Possible reasons for prognostic significance. This study
was not designed to investigate the mechanisms of the in-
creased ventilatory response to exercise in patients with
chronic heart failure. Nevertheless, that it is related to several
indexes of severity suggests that it serves as a compensatory
response to maintain arterial blood gas tension and oxygen
saturation within normal limits during exercise in these pa-
tients. Given that several factors may contribute to the in-
creased ventilatory response to exercise, its prognostic value in
chronic heart failure is more difficult to explain. We showed
that the V˙E–V˙CO2 slope is an important predictor of mortality,
independent of other factors affecting survival in chronic heart
failure, such as peak oxygen consumption and LVEF. Indeed,
if the increased ventilatory response to exercise in patients with
chronic heart failure is due both to ventilation–perfusion
mismatch arising from hemodynamic dysfunction and to the
altered control of ventilation, as indicated by the augmentation
of chemoreflex, then the ventilatory response to exercise may
well assess these aspects of the pathophysiology of heart failure
that also correlate with an advanced stage of the disease.
Abnormal hemodynamic variables are known to be associated
with a poor prognosis in this condition (38,39), and the
mechanisms of augmentation of the chemoreflex may lie in
sympathetic overactivity and neurohormonal imbalance, both
of which also affect survival in chronic heart failure (40,41).
Catecholamines have been shown to increase chemosensitivity
(42), which in turn may further perpetuate the sympathetic
drive and contribute to neurohormonal imbalance (43). The
chemoreflex may also be augmented directly by reduced blood
flow to the chemoreceptors, again reflecting hemodynamic
dysfunction. Thus, patients with an increased V˙E–V˙CO2 slope
have a worse prognosis.
Limitations of the study. This was a retrospective study
that requires prospective confirmation. Similarly, further stud-
ies are required to assess the usefulness of the ventilatory
response to exercise in the monitoring of patients during
treatment. A larger cohort of patients with more severe heart
failure would also be needed to investigate the use of the
V˙E–V˙CO2 slope in the selection and triage of patients for heart
transplantation.
Conclusions. The ventilatory response to exercise may be
used as a supplementary index in the assessment of patients
with chronic heart failure. It is highly reproducible in repeated
cardiopulmonary exercise tests and was abnormal in ;50% of
patients with chronic heart failure in our study. It is also an
important prognostic indicator in chronic heart failure.
Figure 2. Kaplan-Meier survival curves for 18-month
follow-up (547 days) showing a significant difference (p ,
0.0001) in survival in patients with a normal ventilatory
response to exercise versus those with a high response.
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